PERINI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.804
AS - Asia 904
EU - Europa 597
SA - Sud America 203
AF - Africa 145
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 9
Totale 4.684
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.724
SG - Singapore 337
CN - Cina 227
BR - Brasile 156
HK - Hong Kong 137
FI - Finlandia 81
IT - Italia 81
DE - Germania 78
SE - Svezia 58
VN - Vietnam 38
FR - Francia 35
UA - Ucraina 30
GB - Regno Unito 27
RU - Federazione Russa 24
PL - Polonia 23
NL - Olanda 18
IN - India 17
AT - Austria 15
TR - Turchia 14
ZA - Sudafrica 13
EC - Ecuador 11
BD - Bangladesh 10
ES - Italia 10
AR - Argentina 9
CA - Canada 9
CI - Costa d'Avorio 9
CY - Cipro 9
IE - Irlanda 9
BA - Bosnia-Erzegovina 8
CH - Svizzera 8
IR - Iran 8
MX - Messico 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
CR - Costa Rica 7
CV - Capo Verde 7
DZ - Algeria 7
IS - Islanda 7
KG - Kirghizistan 7
MK - Macedonia 7
NC - Nuova Caledonia 7
PK - Pakistan 7
AD - Andorra 6
AO - Angola 6
AU - Australia 6
BB - Barbados 6
BG - Bulgaria 6
GT - Guatemala 6
JP - Giappone 6
KR - Corea 6
MD - Moldavia 6
PR - Porto Rico 6
PS - Palestinian Territory 6
PY - Paraguay 6
TN - Tunisia 6
UZ - Uzbekistan 6
AF - Afghanistan, Repubblica islamica di 5
CL - Cile 5
CM - Camerun 5
DK - Danimarca 5
GR - Grecia 5
HR - Croazia 5
KZ - Kazakistan 5
LV - Lettonia 5
MA - Marocco 5
MN - Mongolia 5
PA - Panama 5
RE - Reunion 5
SN - Senegal 5
TT - Trinidad e Tobago 5
XK - ???statistics.table.value.countryCode.XK??? 5
AL - Albania 4
AM - Armenia 4
BE - Belgio 4
CD - Congo 4
ET - Etiopia 4
GE - Georgia 4
GN - Guinea 4
GP - Guadalupe 4
IQ - Iraq 4
ME - Montenegro 4
ML - Mali 4
MW - Malawi 4
RS - Serbia 4
SI - Slovenia 4
ZW - Zimbabwe 4
AZ - Azerbaigian 3
BO - Bolivia 3
BS - Bahamas 3
BW - Botswana 3
BY - Bielorussia 3
BZ - Belize 3
CU - Cuba 3
CW - ???statistics.table.value.countryCode.CW??? 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GA - Gabon 3
GH - Ghana 3
GM - Gambi 3
Totale 4.572
Salva come PNG Salva come JPEG
Città #
Chandler 319
Fairfield 319
Woodbridge 270
Singapore 213
Ashburn 204
Ann Arbor 197
Santa Clara 161
Hong Kong 135
Cambridge 132
Wilmington 130
Seattle 118
Houston 113
Jacksonville 99
Beijing 72
Princeton 68
Boardman 64
Nanjing 34
Helsinki 31
Medford 25
San Diego 25
Buffalo 18
Los Angeles 18
Norwalk 18
Roxbury 18
Bytom 17
Ho Chi Minh City 17
Munich 17
Des Moines 16
São Paulo 16
Guangzhou 15
Padova 15
Hanoi 13
Redondo Beach 13
New York 11
Nuremberg 10
Shenyang 10
Abidjan 8
Jiaxing 8
Milan 8
Nanchang 8
Nicosia 8
Vienna 8
Bishkek 7
Dublin 7
London 7
Noumea 7
Andorra la Vella 6
Bridgetown 6
Brooklyn 6
Changsha 6
Falkenstein 6
Guatemala City 6
Johannesburg 6
Luanda 6
Praia 6
Reykjavik 6
Tashkent 6
Belo Horizonte 5
Boston 5
Brasília 5
Dakar 5
Dallas 5
Guayaquil 5
Hebei 5
Hefei 5
Istanbul 5
Pristina 5
Riga 5
San José 5
Skopje 5
Tianjin 5
Turku 5
Ulan Bator 5
Abu Dhabi 4
Bamako 4
Chisinau 4
Conakry 4
Harare 4
Kinshasa 4
Les Abymes 4
Ogden 4
Panama City 4
Podgorica 4
San Francisco 4
Sofia 4
Tokyo 4
Accra 3
Addis Ababa 3
Antakya 3
Asunción 3
Athens 3
Banjul 3
Belém 3
Buenos Aires 3
Campinas 3
Campo Grande 3
Casablanca 3
Chaguanas 3
Chennai 3
Chicago 3
Totale 3.287
Salva come PNG Salva come JPEG
Nome #
Cortical relapses in multiple sclerosis 173
Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset 153
A case of relapsing-remitting tumour-like inflammation of the central nervous system 151
Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis. 149
Investigation of the neural correlates underlying action observation in multiple sclerosis patients 147
Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study. 144
MRI-detectable cortical lesions in the cerebellum and their clinical relevance in multiple sclerosis 141
Cortical lesions and cognitive impairment in multiple sclerosis. 132
Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study 132
Gray matter pathology in MS: A 3-year longitudinal study in a pediatric population 131
Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis 128
Cortical Pathology in RRMS: Taking a Cue from Four Sisters. 121
Increased incidence of multiple sclerosis in the Veneto region, Italy. 118
Increasing Frequency of Multiple Sclerosis in Padova, Italy. A 30 year epidemiological survey 113
Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings. 112
Crisi epilettiche all’esordio e al follow-up in ADEM ed sclerosi multipla con esordio in età pediatrica: dati a confronto dalla casistica padovana 108
Extensive cortical inflammation is associated with epilepsy in multiple sclerosis 107
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study 106
Low degree of cortical pathology is associated with benign course of multiple sclerosis. 106
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study 106
The range of multiple sclerosis associated with neurofibromatosis type 1 103
Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks 102
Mitoxantrone versus cyclophosphamide in secondary-progressive multiple sclerosis - A comparative study 101
Multiple sclerosis and autoimmune diseases - Epidemiology and HLA-DR association in North-east Italy 101
Immunotherapies for Multiple Sclerosis. 96
Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study. 95
Il “mirror IgG pattern” nella diagnostica delle malattie neurologiche. 95
Crisi epilettiche all’esordio e al follow-up in ADEM e sclerosi multipla in età pediatrica: dati a confronto dalla casistica padovana 94
Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon beta-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study 93
Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo. 88
Crebrospinal fluid examination in the differential diagnosis of inflammato ry myelopathies 86
Anti-interferon beta (IFNbeta) antibodies in IFNbeta1a- or IFNbeta1b-treated relapsing-remitting multiple sclerosis. Prevalence, kinetics, cross-reactivity, and factors enhancing their production in vivo 85
Meningiti croniche non infettive. 85
The clinical impact of interferon beta antibodies in relapsing remitting MS 83
Malattie Infiammatorie del Sistema Nervoso Centrale. 82
Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients. 79
Effect of Immunomodulatory Agents (IMAs) on Cortical Inflammatory Lesions (CLs) in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): A 2-Year Longitudinal Comparison Study 76
Complicanze neurologiche delle Malattie Dismetaboliche 75
Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a. 71
Sclerosi Multipla 69
Autoanticorpi naturali anti-interferone beta (IFNβ) in pazienti con sclerosi multipla trattati con IFNβ1a (Avonex) o IFNβ1b (Betaferon). 69
The safety profile of cyclophosphamide in multiple sclerosis trherapy. 67
The changing clinical course of multiple sclerosis: A matter of grey matter. 62
null 60
The HLA-DR13 aplotype is associated with benign multiple sclerosis in North-east Italy 54
The MBP-reactive repertoire is shaped by recognition of minor histocompatibility antigens 47
Totale 4.696
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.149
article - articoli 12.824
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.677
Totale 29.650
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021227 0 0 7 24 18 17 4 29 43 14 38 33
2021/2022455 28 48 51 13 24 50 4 44 29 16 49 99
2022/2023512 105 75 16 72 79 64 5 24 50 1 20 1
2023/2024227 11 46 35 16 7 19 7 26 7 6 22 25
2024/20251.037 4 90 54 46 191 26 38 93 60 34 158 243
2025/2026880 149 317 414 0 0 0 0 0 0 0 0 0
Totale 4.696